VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
CME
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
CMECME Group Inc.
$319.37$114.8B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCMEBalance Sheet

CME Group Inc. (CME) Balance Sheet

26Y historyFree accessUpdated daily

Total assets expanded about 56% to $192.1B entirely on the liability side while equity held near $26.6B, driving equity-to-assets down from 0.22 to 0.14 and leaving just $2.2B of cash plus $131.0M of investment securities against $165.5B of liabilities.

Income StatementBalance SheetCash FlowRatios

CME Balance Sheet

Annual statement

CME Balance Sheet

CME Group Inc. (CME) balance sheet — 26-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00
Cash & Short Term Investments11.66B4.54B3.01B3.02B2.82B2.95B1.73B1.63B1.45B1.99B1.95B1.77B1.44B2.54B1.66B10.42B4.94B6.29B607.97M1.05B3.87B3.66B747.51M812.17M3.15B1.9B30.66M
Cash & Due from Banks2.2B4.42B2.89B2.91B2.72B2.83B1.63B1.55B1.37B1.9B1.87B1.69B1.37B2.47B1.6B1.04B855.2M260.6M297.89M845.31M969.5M610.89M357.56M185.12M339.26M69.1M30.66M
Short Term Investments131M125M113.2M111.7M96M115M100.9M83.2M72.9M90.1M83.3M72.5M74.7M68.4M56.6M9.38B4.09B6.02B310.08M203.31M2.9B3.05B389.95M627.04M2.81B1.83B0
Total Investments131M125M113.2M111.7M96M115M100.9M83.2M72.9M90.1M83.3M72.5M74.7M68.4M56.6M47.6M4.09B6.02B310.1M203.31M2.9B3.05B389.95M627.04M2.81B1.83B0
Investments Growth %37.53%10.42%1.34%16.35%-16.52%13.97%21.27%14.13%-19.09%8.16%14.9%-2.95%9.21%20.85%18.91%-98.84%-32.13%1842.76%52.53%-92.99%-4.72%681.1%-37.81%-77.71%53.8%--
Long-Term Investments000000000000000000000000000
Accounts Receivables788.1M639.2M573.1M535.6M483.2M434.5M461.3M491.8M553.3M359.7M364.4M357.8M341.2M302.7M267.5M289.4M297.5M248.3M234M187.49M121.13M86.98M78.83M52.97M50.87M40.99M28.53M
Goodwill & Intangibles30.12B30.3B30.48B30.72B30.93B31.24B32.84B33.04B33.48B27.09B27.19B27.28B27.38B27.49B27.6B28.34B28.48B27.78B27.87B14.83B24.27M000000
Goodwill10.51B10.51B10.49B10.5B10.48B10.53B10.8B10.74B10.81B7.57B7.57B7.57B7.57B7.57B7.57B7.98B7.98B7.55B7.52B5.05B11.5M000000
Intangible Assets19.62B19.79B20B20.23B20.45B20.71B22.04B22.29B22.68B19.52B19.62B19.71B19.81B19.92B20.03B20.35B20.49B20.23B20.35B9.78B12.78M000000
PP&E (Net)338.7M362.7M386.2M409.5M455.5M505.3M579.2M544M448.7M399.7M425.2M491.7M508.9M513.4M724M821.9M786.8M738.5M707.2M377.45M168.75M153.33M131.36M118.2M109.56M100.99M80.39M
Other Assets2.49B2.4B3.54B3.69B3.71B3.28B1.96B2.07B1.66B1.39B1.73B1.68B1.81B1.87B1.83B653.7M394.4M435.8M469.4M108.69M52.28M32.64M31.24M31.05M30.32M19.78M33.62M
Total Current Assets159.14B165.36B103.03B94.89B139.08B161.76B89.28B39.57B41.89B46.91B40.03B37.9B42.55B24.41B8.72B10.95B5.39B6.7B19.11B4.99B4.03B3.78B2.69B4.72B3.22B1.95B267.43M
Total Non-Current Assets32.95B33.06B34.41B34.82B35.1B35.02B35.38B35.65B35.59B28.88B29.34B29.45B29.7B29.87B30.15B29.81B29.66B28.95B29.05B15.32B276.25M185.97M162.6M149.26M139.88M120.77M114.01M
Total Assets192.09B198.42B137.45B129.71B174.18B196.78B124.66B75.22B77.48B75.79B69.37B67.36B72.24B54.28B38.86B40.76B35.05B35.65B48.16B20.31B4.31B3.97B2.86B4.87B3.36B2.07B381.44M
Asset Growth %83.2%44.36%5.97%-25.53%-11.49%57.85%65.74%-2.92%2.22%9.26%2.98%-6.76%33.1%39.66%-4.65%16.3%-1.7%-25.97%137.16%371.52%8.49%38.91%-41.36%45.23%62.32%441.86%-
Return on Assets (ROA)2.24%2.41%2.64%2.12%1.45%1.64%2.11%2.77%2.56%5.6%2.24%1.79%1.78%2.1%2.25%4.78%2.69%1.97%2.09%5.35%9.84%8.99%5.68%2.97%3.47%5.58%-1.55%
Accounts Payable67.7M71.8M79.9M90.6M121.4M48.8M69.3M61.9M116M31.3M26.2M28.7M36.9M36.2M41.7M31.1M51.8M46.7M71M58.97M25.55M23.55M23.05M24.69M27.61M23.83M11.9M
Total Debt3.43B3.42B3.43B3.43B3.44B3.45B3.44B3.74B4.4B46.42B39.77B37.78B42.67B2.86B2.86B11.44B2.53B2.31B3.22B164.44M521.18M001.51M2.33M6.65M6.06M
Net Debt1.23B-994.6M535.6M513.4M718.3M610.2M1.81B2.19B3.03B44.51B37.91B36.09B41.31B387.4M1.25B10.4B1.67B2.05B2.92B-680.88M-448.32M-610.89M-357.56M-183.61M-336.93M-62.45M-24.59M
Long-Term Debt3.43B3.42B2.68B3.43B3.42B2.7B3.44B3.74B3.83B2.23B2.23B2.23B2.11B2.11B2.11B2.11B2.1B2.01B2.97B000002.33M6.65M6.06M
Short-Term Debt00749.8M016M749.4M00574.2M44.19B37.54B35.55B40.57B749.9M749.7M9.33B420.5M299.8M249.9M164.44M521.18M001.51M000
Other Liabilities785.6M734.8M721.2M798.2M826M896.5M1.06B1.16B745.1M615.7M560.9M395.5M376.2M449.4M220.5M187.6M191.5M165.8M132.7M76.26M32.06M20.78M19.25M21.67M17.05M10.02M13.42M
Total Current Liabilities156.11B160.3B102.31B93.42B137.69B160.4B88.2B38.52B41.27B45.67B38.95B36.82B41.53B23.31B7.62B9.62B4.78B6.52B18.64B4.08B2.76B2.83B2.03B4.29B2.89B1.8B198.29M
Total Non-Current Liabilities9.42B9.4B8.65B9.55B9.61B8.98B10.11B10.53B10.24B7.71B10.08B9.98B9.79B9.81B9.74B9.52B10.14B9.83B10.83B3.92B32.06M20.78M19.25M21.67M19.38M16.67M19.48M
Total Liabilities165.53B169.7B110.96B102.97B147.3B169.38B98.31B49.06B51.51B53.38B49.03B46.81B51.32B33.12B17.36B19.14B14.92B16.35B29.47B8B2.79B2.85B2.04B4.31B2.91B1.82B217.77M
Total Equity26.56B28.73B26.49B26.74B26.88B27.4B26.35B26.16B25.97B22.41B20.34B20.55B20.92B21.16B21.51B21.62B20.13B19.3B18.69B12.31B1.52B1.12B812.6M563M446.14M248.37M163.67M
Equity Growth %-3.24%8.46%-0.94%-0.52%-1.9%3.98%0.73%0.75%15.86%10.18%-1.03%-1.78%-1.12%-1.61%-0.54%7.42%4.29%3.28%51.87%710.07%35.79%37.67%44.33%26.19%79.63%51.75%-
Equity / Assets (Capital Ratio)13.83%14.48%19.27%20.61%15.43%13.92%21.14%34.78%33.51%29.57%29.32%30.51%28.96%38.99%55.34%53.05%57.43%54.14%38.81%60.6%35.27%28.18%28.44%11.55%13.3%12.02%42.91%
Return on Equity (ROE)16.24%14.65%13.25%12.03%9.92%9.81%8.02%8.12%8.11%19.01%7.5%6.01%5.36%4.58%4.16%8.68%4.83%4.35%4.62%9.53%30.89%31.78%31.92%24.21%27.09%33.15%-3.61%
Book Value per Share74.0679.7573.5974.3874.8376.3473.5073.0275.5465.8760.0160.8262.2663.2864.7164.7760.5458.0163.3955.808.656.424.723.322.971.701.14
Tangible BV per Share-9.93-4.37-11.10-11.08-11.27-10.69-18.10-19.19-21.86-13.75-20.19-19.92-19.22-18.91-18.33-20.12-25.11-25.48-31.14-11.468.516.424.723.322.971.701.14
Common Stock3.6M3.6M3.6M3.6M3.6M3.6M3.6M3.6M3.6M3.4M3.4M3.4M3.4M3.3M3.3M3.3M700K700K700K533K348K345K341K329K325K288K288K
Additional Paid-in Capital022.21B22.4B22.33B22.26B22.19B21.19B21.11B21.05B17.9B17.83B17.72B17.6B17.5B17.21B17.11B17.28B17.19B17.13B10.69B405.51M324.85M261.05M195.22M179.67M59.23M43.88M
Retained Earnings6.03B6.43B4.19B4.46B4.75B5.15B5B5.01B4.86B4.5B2.52B2.91B3.32B3.49B3.99B4.32B2.89B2.24B1.72B1.62B1.12B796.4M552.8M368.31M266.81M190.03M119.51M
Accumulated OCI55.5M81.9M-105.5M-55.6M-133.3M53.5M134.9M3.4M5.3M14.3M-14.1M-80.8M6.2M152M209.3M111.6M-104.1M-126.2M-160.3M-3.1M-2.98M-2.91M-1.59M-868K-665K-1.18M-11K
Treasury Stock000000000000000000000000000
Preferred Stock000000000000000000000000000

Key Metrics

Growth RegimeExpanding
ProfitabilityStrong
Balance SheetFortress
Cash FlowRobust
Top Statement Risk

Counterparty exposure outpacing capital

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Asset Growth Liability-Driven

According to CME's reported balance sheet, total assets expanded roughly 56% over ten quarters, from $123.4B in 2024Q2 to $192.1B in 2026Q3, while equity was essentially flat at $26.6B, meaning the entire expansion sits on the liability side rather than in invested assets.

This is not balance sheet expansion in the industrial sense; the growth appears attributable to accumulated clearing member performance bonds and deposits, which are custodial in nature and move with margin requirements rather than with lending activity. Investors should avoid reading the $69B asset increase as balance sheet deepening — it reflects CME's growing clearing franchise and collateral throughput, which explains why the equity base was permitted to stay flat while ROE drifted between 3.2% and 4.2%.

Collateral Replaces Deposit Franchise

The funding franchise is dominated by clearing member collateral rather than retail or corporate deposits: total liabilities of $165.5B in 2026Q3 far outstrip the $2.2B of cash and bank balances held, and net interest income has swung from -$44.0M to $1.4B across eight quarters, per CME's quarterly disclosures.

CME's funding stability derives from the stickiness of margin posted against open futures positions, not from insured or relationship deposits, so the liability base should be read as a volatility-linked float rather than a classic deposit franchise. The NII discontinuity suggests interest earned on client collateral has become a material and rate-sensitive earnings component, which may indicate that funding economics are increasingly hostage to where policy rates settle rather than to CME's own pricing power.

Provision Spike Flags Clearing Risk

CME carries no traditional loan book — the loan-to-deposit field is blank throughout — yet provision for credit losses spiked to $568.3M in 2026Q2, more than triple the $165M-$197M quarterly range of 2024-2025, before falling to $60.7M in Q3, as disclosed in CME's financial statements.

With no loans outstanding, this line can only be interpreted as clearing member, default fund, or guarantee-related credit assessment, and the magnitude of the Q2 charge against record volumes suggests an episodic event rather than gradual portfolio deterioration. The pattern is consistent with a recalibration of counterparty risk reserves, but the data provided do not identify the driver, so analysts should treat the subsequent normalization to $60.7M cautiously rather than as resolution.

Capital Flat as Assets Inflate

Equity has hovered near $26.5-$28.7B for ten quarters, but the equity-to-assets ratio has compressed from 0.22 to 0.14 not through capital erosion — the asset base simply grew faster; according to CME's reported figures, ROE of 3.9% in 2026Q3 sits below the 4.2% printed in 2026Q1.

The capital cushion itself appears intact in absolute terms, and prior cash flow findings showing a $2.7B variable dividend in 2026Q1 and $698.2M of buybacks in Q2 confirm management is distributing surplus rather than retaining it. The declining ratio is therefore an optics artifact of collateral accumulation, but it does mean each dollar of capital now stands behind a larger pool of default-related obligations, warranting closer scrutiny of capital relative to clearing exposure than relative to assets.

Thin Securities Buffer by Design

Liquid assets are strikingly thin relative to the balance sheet: $2.2B of cash and bank balances and just $131.0M of investment securities against $192.1B of total assets in 2026Q3, implying liquidity rests on collateral mobility rather than portfolio holdings, based on CME's reported balance sheet.

The near-absence of a securities book — with the sole exception of $1.6B in 2025Q4 — indicates CME deliberately avoids duration and unrealized-loss exposure, keeping its treasury function minimal and its balance sheet free of the AOCI drag that burdens rate-sensitive peers. This is a structurally conservative posture, though it also means the provided data reveal no meaningful contingent liquidity buffer; committed facility capacity is not disclosed here and warrants further investigation.

Growth May Mask Rising Exposure

The most under-appreciated risk is that CME's balance sheet growth may signal rising counterparty exposure rather than strength: assets grew 56% while provisions reached $568.3M and equity stayed flat, a combination suggesting default-related claims could be accumulating faster than capital, per CME's quarterly data.

Analysts typically treat a 56% asset increase as expansion, but for a clearinghouse whose assets are largely claims arising from member defaults and collateral, the more relevant question is whether the obligations backing that growth are matched by capital that has not moved in ten quarters. Read alongside the volatile NII line and the Q2 provision surge, this suggests the balance sheet's apparent fortress quality may be understating the sensitivity of CME's capital to a severe clearing member stress event.

CME — Frequently Asked Questions

Quick answers to the most common questions about buying CME stock.

What are the total assets of CME Group Inc. (CME)?

As of 2025, CME Group Inc. (CME) had total assets of $198.42B including $165.36B in current assets.

How much debt does CME Group Inc. (CME) have?

CME Group Inc. (CME) carries total debt of $3.42B. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of CME Group Inc.?

CME Group Inc. (CME) has total shareholders' equity (book value) of $28.73B ($79.75 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is CME Group Inc.'s current ratio and liquidity?

CME Group Inc. (CME) reported a current ratio of 1.03x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.